ArriVent BioPharma, Inc. AVBP Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $37.62M+16.9% | $32.18M0.0% | $32.17M+16.0% | $27.72M-54.8% | $61.29M+204% | ||
| $8.49M+27.8% | $6.65M+8.1% | $6.15M+4.2% | $5.9M+7.7% | $5.48M+54.8% | ||
| $46.11M+18.8% | $38.82M+1.3% | $38.32M+14.0% | $33.62M-49.6% | $66.77M+182% | ||
| $46.11M+18.8% | $38.82M+1.3% | $38.32M+14.0% | $33.62M-49.6% | $66.77M+182% | ||
| -$46.11M-18.8% | -$38.82M-1.3% | -$38.32M-14.0% | -$33.62M+49.6% | -$66.77M-182% | ||
| $2.79M-14.9% | $3.28M-1.8% | $3.34M+50.1% | $2.22M-6.8% | $2.39M-22.4% | ||
| -$43.32M-21.9% | -$35.54M-1.6% | -$34.98M-11.4% | -$31.4M+51.2% | -$64.39M-212% | ||
| -$0.96-23.1% | -$0.78+6.0% | -$0.83+7.8% | -$0.90+52.6% | -$1.90-211% | ||
| -$0.96-23.1% | -$0.78+6.0% | -$0.83+7.8% | -$0.90+52.6% | -$1.90-211% | ||
| 45.1M+17.2% | 38.5M-8.2% | 41.9M+19.7% | 35M+3.3% | 33.9M+7.7% | ||
| 45.1M+17.2% | 38.5M-8.2% | 41.9M+19.7% | 35M+3.3% | 33.9M+7.7% | ||
| -$43.6M-22.0% | -$35.74M-2.8% | -$34.75M-10.7% | -$31.4M+51.1% | -$64.19M-208% | ||
| $2.79M-14.9% | $3.28M-1.8% | $3.34M+50.1% | $2.22M-6.8% | $2.39M-22.4% | ||
| -$284K— | —— | $226K+22,700% | -$1K-101% | $194K+468% | ||
| -$284K— | —— | $226K+22,700% | -$1K-101% | $194K+468% | ||
| -$46.11M-18.8% | -$38.82M-1.3% | -$38.32M-14.0% | -$33.62M+49.6% | -$66.77M-182% | ||
| -$46.67M-17.9% | -$39.58M-1.3% | -$39.07M-13.7% | -$34.38M+49.1% | -$67.53M— | ||
| -$46.67M-17.9% | -$39.58M-1.3% | -$39.07M-13.7% | -$34.38M+49.1% | -$67.53M— | ||
| -$46.11M-18.8% | -$38.82M-1.3% | -$38.32M-14.0% | -$33.62M+49.6% | -$66.77M-182% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is ArriVent BioPharma, Inc. profitable?
- ArriVent BioPharma, Inc. is not currently profitable: it reported a net loss of $145.2M over the trailing twelve months.
- What is ArriVent BioPharma, Inc.'s earnings per share?
- ArriVent BioPharma, Inc.'s diluted EPS over the trailing twelve months is $-3.47.
- Where does ArriVent BioPharma, Inc.'s income statement data come from?
- Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.